Key Dates

Related Announcements

• August 25, 2022 - Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional). See NOFO PAR-23-024.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this notice is to inform applicants of a change to the Page Limits and Due Dates for PAR-23-024- “Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- CT Optional)”

Changes to the PAR are shown below:

Currently reads:

Key Dates

Open Date (Earliest Submission Date)

April 01, 2023

Letter of Intent Due Date(s)

30 days prior to the application due date.

Section IV.2 Content and Form of Application Submission

SF424(R&R) Cover

Proposed Project:  Start date: For FY2024 enter 12/01/2023; For FY2025 enter 12/01/2024; For FY2026 enter 12/01/2025

PHS 398 Research Plan

Research Strategy: Upload the Essay here (Six pages total)

Describe your innovative vision for addressing a major problem related to HIV comorbidities, coinfections, and complications within the mission of one or more of the participating components. Explain the importance of this problem or challenge, and your qualifications to lead this project. No detailed scientific plan should be provided since the research plan is expected to evolve during the tenure of the grant. The essay should include the following sections in the order given with the headings as shown below:

Note: References are not required but if included must fit within the six-page limit. Figures and illustrations may be included but must also fit within the six-page limit. Information on collaborators may be included in the Essay and their names and affiliations should be listed in the Cover Letter.

Modified to Read (changes shown in bold italics):

Key Dates

Open Date (Earliest Submission Date)

August 01, 2023

Letter of Intent Due Date(s)

30 days prior to the application due date.

Section IV.2 Content and Form of Application Submission

SF424(R&R) Cover

Proposed Project:  Start date: For FY2024 enter 04/01/2024; For FY2025 enter 12/01/2024; For FY2026 enter 12/01/2025

PHS 398 Research Plan

Research Strategy: Upload the Essay here (Five pages total)

Describe your innovative vision for addressing a major problem related to HIV comorbidities, coinfections, and complications within the mission of one or more of the participating components. Explain the importance of this problem or challenge, and your qualifications to lead this project. No detailed scientific plan should be provided since the research plan is expected to evolve during the tenure of the grant. The essay should include the following sections in the order given with the headings as shown below:

Note: References are not required but if included must fit within the five-page limit. Figures and illustrations may be included but must also fit within the five-page limit. Information on collaborators may be included in the Essay and their names and affiliations should be listed in the Cover Letter.

All other aspects of this PAR remain unchanged.

Inquiries

Please direct all inquiries to:

Peter J. Perrin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: Peter.Perrin@nih.gov